MEK-Inhibition verbessert Therapie mit BRAF-Hemmern bei malignem Melanom
Crossref DOI link: https://doi.org/10.1007/s15012-015-1747-6
Published Online: 2015-01-28
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bublak, Robert
Text and Data Mining valid from 2015-01-28